Developing an influenza vaccine using lipid nanoparticle-encapsulated nucleoside-modified mRNA

被引:0
|
作者
Pardi, N. [1 ]
Naradikian, M. S. [1 ]
Parkhouse, K. [2 ]
Hensley, S. E. [2 ]
Cancro, M. P. [1 ]
Weissman, D. [1 ]
机构
[1] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[2] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
1349
引用
收藏
页码:1232 / 1233
页数:2
相关论文
共 50 条
  • [21] Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice
    Freyn, Alec W.
    Pine, Matthew
    Rosado, Victoria C.
    Benz, Marcel
    Muramatsu, Hiromi
    Beattie, Mitchell
    Tam, Ying K.
    Krammer, Florian
    Palese, Peter
    Nachbagauer, Raffael
    McMahon, Meagan
    Pardi, Norbert
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 22 : 84 - 95
  • [22] Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
    Norbert Pardi
    Kaela Parkhouse
    Ericka Kirkpatrick
    Meagan McMahon
    Seth J. Zost
    Barbara L. Mui
    Ying K. Tam
    Katalin Karikó
    Christopher J. Barbosa
    Thomas D. Madden
    Michael J. Hope
    Florian Krammer
    Scott E. Hensley
    Drew Weissman
    Nature Communications, 9
  • [23] Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
    Pardi, Norbert
    Parkhouse, Kaela
    Kirkpatrick, Ericka
    McMahon, Meagan
    Zost, Seth J.
    Mui, Barbara L.
    Tam, Ying K.
    Kariko, Katalin
    Barbosa, Christopher J.
    Madden, Thomas D.
    Hope, Michael J.
    Krammer, Florian
    Hensley, Scott E.
    Weissman, Drew
    NATURE COMMUNICATIONS, 2018, 9
  • [24] Probing the interaction mechanisms of lipid nanoparticle-encapsulated mRNA with surfaces of diverse functional groups: Implication for mRNA transport
    Wang, Jingyi
    Zhang, Jiawen
    Li, Sijia
    Qian, Hui
    Liu, Dengfeng
    Prado, Isaias
    Wang, Sharon
    Bhambhani, Akhilesh
    Zeng, Hongbo
    CHEMICAL ENGINEERING SCIENCE, 2025, 301
  • [25] Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus
    Furey, Colleen
    Scher, Gabrielle
    Ye, Naiqing
    Kercher, Lisa
    DeBeauchamp, Jennifer
    Crumpton, Jeri Carol
    Jeevan, Trushar
    Patton, Christopher
    Franks, John
    Rubrum, Adam
    Alameh, Mohamad-Gabriel
    Fan, Steven H. Y.
    Phan, Anthony T.
    Hunter, Christopher A.
    Webby, Richard J.
    Weissman, Drew
    Hensley, Scott E.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [26] Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates (Dec, 10.1038/s41541-02100307-6, 2020)
    Saunders, Kevin O.
    Pardi, Norbert
    Parks, Robert
    Santra, Sampa
    Mu, Zekun
    Sutherland, Laura
    Scearce, Richard
    Barr, Maggie
    Eaton, Amanda
    Hernandez, Giovanna
    Goodman, Derrick
    Hogan, Michael J.
    Tombacz, Istvan
    Gordon, David N.
    Rountree, R. Wes
    Wang, Yunfei
    Lewis, Mark G.
    Pierson, Theodore C.
    Barbosa, Chris
    Tam, Ying
    Matyas, Gary R.
    Rao, Mangala
    Beck, Zoltan
    Shen, Xiaoying
    Ferrari, Guido
    Tomaras, Georgia D.
    Montefiori, David C.
    Weissman, Drew
    Haynes, Barton F.
    NPJ VACCINES, 2021, 6 (01)
  • [27] Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation
    Gouma, Sigrid
    Furey, Colleen
    Santos, Jefferson J. S.
    Parkhouse, Kaela
    Weirick, Madison
    Muramatsu, Hiromi
    Pardi, Norbert
    Fan, Steven H. Y.
    Weissman, Drew
    Hensley, Scott E.
    JOURNAL OF VIROLOGY, 2023, 97 (01)
  • [28] A single vaccination of nucleoside-modified Rabies mRNA vaccine induces prolonged highly protective immune responses in mice
    Bai, Shimeng
    Yang, Tianhan
    Zhu, Cuisong
    Feng, Meiqi
    Zhang, Li
    Zhang, Ziling
    Wang, Xiang
    Yu, Rui
    Pan, Xinghao
    Zhao, Chen
    Xu, Jianqing
    Zhang, Xiaoyan
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [29] Pharmacokinetic Analyses of a Lipid Nanoparticle-Encapsulated mRNA-Encoded Antibody against Rift Valley Fever Virus
    Wang, Shuo
    Zhu, Ziling
    Li, Jianmin
    MOLECULAR PHARMACEUTICS, 2024, 21 (03) : 1342 - 1352
  • [30] Developing mRNA lipid nanoparticle vaccine effective for cryptococcosis in a murine model
    Li, Yeqi
    Ambati, Suresh
    Meagher, Richard B.
    Lin, Xiaorong
    NPJ VACCINES, 2025, 10 (01)